Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Stock is 

SEC Filing Details

Document Details

Form
Filing Date
Feb 12, 2021
Document Date
Feb 10, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Agios Pharmaceuticals, Inc.
Issuer
AGIOS PHARMACEUTICALS, INC.
Filer
Car Bruce